CDR2 Polyclonal Antibody | G-AB-00895

CDR2 Polyclonal Antibody | G-AB-00895 | Gentaur Antibodies

Overview: CDR2 (cerebellar degeneration-related protein 2) , also referred to as Yo or CDR62, is a 545 amino acid protein that is associated with the development of paraneoplastic cerebellar degeneration (PCD) . PCD, an immune-mediated syndrome, belongs to a heterogeneous group of rare paraneoplastic neurologic disorders affecting the neurological system. PCD is characterized by subacute cerebellar ataxia and occurs mainly in patients with ovarian, uterine, fallopian tube or breast cancer.

Category Type: Polyclonal Antibody

Research Areas: Cancer, Immunology

Synonyms: AA617262, CDR 2, CDR 62, CDR2, CDR2, CDR62, Cerebellar degeneration related protein 2 62kDa, Cerebellar degeneration related protein 2, Cerebellar degeneration related protein, Cerebellar degeneration-related protein 2, Major Yo paraneoplastic antigen, MGC116181, MGC144810, MGC144811, Paraneoplastic cerebellar degeneration associated antigen, Paraneoplastic cerebellar degeneration-associated antigen, PCD 17, PCD17, RGD1310578, Yo, Yo paraneoplastic antigen

Reactivity: Human, Mouse

Host: Rabbit

Isotype: IgG

Gene ID:

Accession #: BC017503

Clonality: Polyclonal

Immunogen: Recombinant protein of human CDR2

Clone #:

Conjugation: Unconjugated

Swissprot: Q01850

Santa Cruz: sc-109228

Calculated MW:

Observed MW:

Concentration: 0.4 mg/mL

Buffer: PBS with 0.05% sodium azide and 50% glycerol, PH7.4

Purification method: Affinity purification

Application: IHC, ELISA

Dilution: IHC 1:50-1:200

Storage: Store at -20°C. Avoid freeze / thaw cycles.

CDR2 Polyclonal Antibody DataSheet